- Report
- March 2024
- 291 Pages
Global
From €5355EUR$5,600USD£4,589GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1912EUR$2,000USD£1,639GBP
- Report
- November 2023
- 157 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- November 2020
- 53 Pages
Global
From €4733EUR$4,950USD£4,056GBP
- Clinical Trials
- June 2022
- 60 Pages
Global
From €1434EUR$1,500USD£1,229GBP
- Report
- January 2022
- 200 Pages
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,237GBP
- Report
- January 2022
- 110 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- August 2022
- 116 Pages
Global
From €4303EUR$4,500USD£3,687GBP
- Report
- November 2021
- 177 Pages
Global
From €10514EUR$10,995USD£9,009GBP
- Clinical Trials
- December 2019
- 586 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Drug Pipelines
- November 2019
- 367 Pages
Global
From €1912EUR$2,000USD£1,639GBP
- Report
- May 2022
- 188 Pages
Global
From €2391EUR$2,500USD£2,049GBP
- Report
- May 2022
- 44 Pages
Global
From €1912EUR$2,000USD£1,639GBP
The Sepsis Drug market is a subset of the larger Infectious Diseases Drugs market. Sepsis is a life-threatening condition caused by the body's response to an infection. It is a major cause of death worldwide, and the drugs used to treat it are an important part of the Infectious Diseases Drugs market. Sepsis drugs are typically antibiotics, antifungals, antivirals, and other immunomodulators. These drugs are used to reduce the severity of the infection and to prevent further complications.
The Sepsis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Johnson & Johnson. Other companies such as Novartis, Bristol-Myers Squibb, and Eli Lilly also have a presence in the market. Show Less Read more